Breaking News. President’s BIG Secret "Leaked" - Just Revealed.

Posted May 11, 2025 | End Times Watch

For all of you who have been anxiously waiting to hear the secret that President Donald Trump teased on Thursday that he was keeping. Here is that secret:

President Donald Trump has announced plans to sign an executive order aimed at significantly reducing prescription drug prices in the United States by 30% to 80%. This initiative, known as the “Most Favored Nation” (MFN) policy, seeks to align U.S. drug costs with the lowest prices paid by other countries. The policy is scheduled to be signed on Monday, May 12, 2025, at 9 a.m. Eastern Time.

What Is the “Most Favored Nation” Policy?

The MFN policy mandates that the U.S. will not pay more for prescription medications than the lowest price paid by any other developed nation. This approach targets the significant disparity where Americans often pay two to ten times more for the same drugs compared to citizens in other countries.

Scope and Implementation

Initially, the policy will apply to drugs administered in doctors’ offices under Medicare Part B, such as cancer infusions, which are known for their high costs. The full details of the executive order have not been disclosed, and it remains unclear whether it will extend to Medicare Part D or Medicaid. Analysts note that while the policy has the potential for significant savings, its implementation may face legal and logistical.

Historical Context

This is not the first time President Trump has attempted to implement the MFN policy. A similar proposal was introduced during his first term in 2020 but was blocked by a federal court due to procedural issues and the lack of Medicare’s negotiating power at the time. The 2022 Inflation Reduction Act, passed by Democrats, has since granted limited negotiating authority to Medicare, potentially facilitating the policy’s implementation.

Industry Response and Potential Impact

The pharmaceutical industry has expressed strong opposition to the MFN policy, arguing that it could undermine profits and stifle innovation. PhRMA CEO Stephen Ubl criticized the plan as detrimental to American patients. Despite this, some bipartisan support exists, with Senators Josh Hawley (R) and Peter Welch (D) introducing a bill that aligns with the MFN approach.

While the policy aims to reduce drug prices significantly, experts caution that its success will depend on effective implementation and the ability to withstand legal challenges. If successful, the MFN policy could lead to substantial savings for American consumers and the healthcare system at large.

This is indeed great news, however, for those who are watching end times prophecy unfold, we are going to wait a few more days to see the outcome of his meeting with Middle Eastern Leaders.

Thank you for supporting my writings. Stay up to date with the scripture/news of the end times, and ask others to subscribe to our free blog www.EndTimesWatch.blog.

May you Trust God to be with you today, and always. Much Love and Prayers headed your way.

River Wilde